Literature DB >> 27798897

High Density of Tumor-infiltrating B-Lymphocytes and Plasma Cells Signifies Prolonged Overall Survival in Adenocarcinoma of the Esophagogastric Junction.

Juliana Knief1, Katharina Reddemann2, Ekaterina Petrova3, Tobias Herhahn2, Ulrich Wellner3, Christoph Thorns2.   

Abstract

BACKGROUND: Tumor-infiltrating lymphocytes (TILs) have been shown to be of prognostic significance in a variety of tumors. Not only T-cell, but also B-cell infiltration is commonly associated with improved survival.
MATERIALS AND METHODS: We assessed the density of tumor-infiltrating B-cells, as well as that of plasma cells, in 210 adenocarcinomas of the esophagogastric junction through immunohistochemical analysis using antibodies against CD20 and CD138.
RESULTS: No correlation between density of B-cells or plasma cells and various clinicopathologic features could be established. High density of tumor-infiltrating B-cells, as well as plasma cells, showed significantly better overall survival (OS) compared to patients with no infiltrates (p=0.047 and p=0.022, respectively). Cox proportional hazard analysis could verify B-cell infiltration as an independent prognostic factor (hazard ratio (HR)=0.683; 95% confidence interval (CI)=0.517-0.901; p=0.007).
CONCLUSION: Plasma cell and B-cell infiltration correlates with prolonged OS and might identify a patient subset with favorable disease course. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Tumor infiltrating B-cells; adenocarcinoma of the esophagogastric junction; tumor infiltrating plasma cells; tumor microenvironment

Mesh:

Substances:

Year:  2016        PMID: 27798897     DOI: 10.21873/anticanres.11107

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  17 in total

1.  Landscape of infiltrating B cells and their clinical significance in human hepatocellular carcinoma.

Authors:  Zhao Zhang; Lijie Ma; Shyamal Goswami; Jiaqiang Ma; Bohao Zheng; Meng Duan; Longzi Liu; Lijun Zhang; Jieyi Shi; Liangqing Dong; Yumeng Sun; Lingyu Tian; Qiang Gao; Xiaoming Zhang
Journal:  Oncoimmunology       Date:  2019-02-07       Impact factor: 8.110

2.  Immune Cells and Immunoglobulin Expression in the Mammary Gland Tumors of Dog.

Authors:  Alessandra Sfacteria; Ettore Napoli; Claudia Rifici; Daria Commisso; Giada Giambrone; Giuseppe Mazzullo; Gabriele Marino
Journal:  Animals (Basel)       Date:  2021-04-21       Impact factor: 2.752

Review 3.  HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer.

Authors:  Tristan A Barnes; Eitan Amir
Journal:  Br J Cancer       Date:  2017-07-13       Impact factor: 7.640

Review 4.  Immune-Mediated Therapies for Liver Cancer.

Authors:  Rajagopal N Aravalli; Clifford J Steer
Journal:  Genes (Basel)       Date:  2017-02-17       Impact factor: 4.096

5.  Hashimoto's thyroiditis attenuates progression of papillary thyroid carcinoma: deciphering immunological links.

Authors:  Oksana Sulaieva; Oleksii Selezniov; Dmytro Shapochka; Nataliia Belemets; Oleksandr Nechay; Yelizaveta Chereshneva; Dibakhan Tsomartova; Marina Ivanova
Journal:  Heliyon       Date:  2020-01-08

6.  Autoantibody Landscape in Patients with Advanced Prostate Cancer.

Authors:  William S Chen; Winston A Haynes; Rebecca Waitz; David Y Oh; John C Shon; Felix Y Feng; Kathy Kamath; Agustin Vega-Crespo; Raunak Shrestha; Minlu Zhang; Adam Foye; Ignacio Baselga Carretero; Ivan Perez Garcilazo; Meng Zhang; Shuang G Zhao; Martin Sjöström; David A Quigley; Jonathan Chou; Tomasz M Beer; Matthew Rettig; Martin Gleave; Christopher P Evans; Primo Lara; Kim N Chi; Robert E Reiter; Joshi J Alumkal; Alan Ashworth; Rahul Aggarwal; Eric J Small; Patrick S Daugherty; Antoni Ribas
Journal:  Clin Cancer Res       Date:  2020-09-23       Impact factor: 12.531

7.  Tumor-infiltrating plasma cells are the promising prognosis marker for esophageal squamous cell carcinoma.

Authors:  Chengyun Yao; Hongliang Yu; Guoren Zhou; Jianhua Xu; Dayong Gu; Li Yin; Xia He; Hongping Xia
Journal:  Esophagus       Date:  2021-03-10       Impact factor: 4.230

8.  Why MUC16 mutations lead to a better prognosis: A study based on The Cancer Genome Atlas gastric cancer cohort.

Authors:  Yu-Jie Huang; Zhi-Fei Cao; Jie Wang; Jian Yang; Yi-Jun Wei; Yu-Chen Tang; Yin-Xiang Cheng; Jian Zhou; Zi-Xiang Zhang
Journal:  World J Clin Cases       Date:  2021-06-16       Impact factor: 1.337

9.  Novel biomarkers for risk stratification of Barrett's oesophagus associated neoplastic progression-epithelial HMGB1 expression and stromal lymphocytic phenotype.

Authors:  Ross J Porter; Graeme I Murray; Daniel P Brice; Russell D Petty; Mairi H McLean
Journal:  Br J Cancer       Date:  2019-12-13       Impact factor: 7.640

10.  Nicotinamide N-Methyltransferase Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer.

Authors:  Miaowei Wu; Weilei Hu; Guosheng Wang; Yihan Yao; Xiao-Fang Yu
Journal:  Front Genet       Date:  2020-10-28       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.